2-Chloroquinoline

Catalog No.: 
ACESKC380
CAS No.: 
612-62-4
Molecular Formula: 
C9H6ClN
Molecular Weight: 
163.61
2-Chloroquinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$159.00In stockIn stock
500g98%$779.00In stockInquiry
1000g98%$1283.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloroquinoline
IUPAC Name2-chloroquinoline
MDL No.MFCD00006741
Molecular FormulaC9H6ClN
Molecular Weight163.61
SMILESC1=CC=CC2=CC=C(N=C12)Cl
InChI KeyOFUFXTHGZWIDDB-UHFFFAOYSA-N
SynonymInChI=1/C9H6ClN/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6H | NSC 6163 | NSC-6163 | SR-01000390732-1 | AC-2439 | CHLOROQUINOLINE, 2- | 2-Chloroquinoline, 99% | Chloroquinoline | EINECS 210-317-8 | F0451-0421 | AI3-08909 | chioroquinoline | Quinoline, chloro- | OFU
CAS No.612-62-4
PubChem CID11928

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACESKC380 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZDAM739 route compound structure diagram
    ACZDAM73970254-42-1In Stock
  2. Then
  3. ACESKC380 route product structure diagram
    ACESKC380612-62-4In Stock
Inquiry

2. ACESKC380 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACELWO958 route compound structure diagram
    ACELWO9581266615-86-4In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACESKC380 route product structure diagram
    ACESKC380612-62-4In Stock
Inquiry

3. ACESKC380 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACESKC380 route product structure diagram
    ACESKC380612-62-4In Stock
Inquiry

Comments (0)